1 Study Coverage 1.1 Stroke Diagnostics and Therapeutics Revenue in Stroke Diagnostics and Therapeutics Business (2017-2022) & (US$ Million) Introduction 1.2 Global Stroke Diagnostics and Therapeutics Outlook 2017 VS 2022 VS 2028 1.2.1 Global Stroke Diagnostics and Therapeutics Market Size for the Year 2017-2028 1.2.2 Global Stroke Diagnostics and Therapeutics Market Size for the Year 2017-2028 1.3 Stroke Diagnostics and Therapeutics Market Size, United States VS Global, 2017 VS 2022 VS 2028 1.3.1 The Market Share of United States Stroke Diagnostics and Therapeutics in Global, 2017 VS 2022 VS 2028 1.3.2 The Growth Rate of Stroke Diagnostics and Therapeutics Market Size, United States VS Global, 2017 VS 2022 VS 2028 1.4 Stroke Diagnostics and Therapeutics Market Dynamics 1.4.1 Stroke Diagnostics and Therapeutics Industry Trends 1.4.2 Stroke Diagnostics and Therapeutics Market Drivers 1.4.3 Stroke Diagnostics and Therapeutics Market Challenges 1.4.4 Stroke Diagnostics and Therapeutics Market Restraints 1.5 Study Objectives 1.6 Years Considered 2 Stroke Diagnostics and Therapeutics by Type 2.1 Stroke Diagnostics and Therapeutics Market Segment by Type 2.1.1 Diagnostics 2.1.2 Therapeutics 2.2 Global Stroke Diagnostics and Therapeutics Market Size by Type (2017, 2022 & 2028) 2.3 Global Stroke Diagnostics and Therapeutics Market Size by Type (2017-2028) 2.4 United States Stroke Diagnostics and Therapeutics Market Size by Type (2017, 2022 & 2028) 2.5 United States Stroke Diagnostics and Therapeutics Market Size by Type (2017-2028) 3 Stroke Diagnostics and Therapeutics by Application 3.1 Stroke Diagnostics and Therapeutics Market Segment by Application 3.1.1 Ischemic Stroke 3.1.2 Haemorrhagic Stroke 3.2 Global Stroke Diagnostics and Therapeutics Market Size by Application (2017, 2022 & 2028) 3.3 Global Stroke Diagnostics and Therapeutics Market Size by Application (2017-2028) 3.4 United States Stroke Diagnostics and Therapeutics Market Size by Application (2017, 2022 & 2028) 3.5 United States Stroke Diagnostics and Therapeutics Market Size by Application (2017-2028) 4 Global Stroke Diagnostics and Therapeutics Competitor Landscape by Company 4.1 Global Stroke Diagnostics and Therapeutics Market Size by Company 4.1.1 Top Global Stroke Diagnostics and Therapeutics Companies Ranked by Revenue (2021) 4.1.2 Global Stroke Diagnostics and Therapeutics Revenue by Player (2017-2022) 4.2 Global Stroke Diagnostics and Therapeutics Concentration Ratio (CR) 4.2.1 Stroke Diagnostics and Therapeutics Market Concentration Ratio (CR) (2017-2022) 4.2.2 Global Top 5 and Top 10 Largest Companies of Stroke Diagnostics and Therapeutics in 2021 4.2.3 Global Stroke Diagnostics and Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 4.3 Global Stroke Diagnostics and Therapeutics Headquarters, Revenue in Stroke Diagnostics and Therapeutics Business (2017-2022) & (US$ Million) Type 4.3.1 Global Stroke Diagnostics and Therapeutics Headquarters and Area Served 4.3.2 Global Stroke Diagnostics and Therapeutics Companies Revenue in Stroke Diagnostics and Therapeutics Business (2017-2022) & (US$ Million) Type 4.3.3 Date of International Companies Enter into Stroke Diagnostics and Therapeutics Market 4.4 Companies Mergers & Acquisitions, Expansion Plans 4.5 United States Stroke Diagnostics and Therapeutics Market Size by Company 4.5.1 Top Stroke Diagnostics and Therapeutics Players in United States, Ranked by Revenue (2021) 4.5.2 United States Stroke Diagnostics and Therapeutics Revenue by Players (2020, 2021 & 2022) 5 Global Stroke Diagnostics and Therapeutics Market Size by Region 5.1 Global Stroke Diagnostics and Therapeutics Market Size by Region: 2017 VS 2022 VS 2028 5.2 Global Stroke Diagnostics and Therapeutics Market Size by Region (2017-2028) 5.2.1 Global Stroke Diagnostics and Therapeutics Market Size by Region: 2017-2022 5.2.2 Global Stroke Diagnostics and Therapeutics Market Size by Region (2023-2028) 6 Segment in Region Level & Country Level 6.1 North America 6.1.1 North America Stroke Diagnostics and Therapeutics Market Size YoY Growth 2017-2028 6.1.2 North America Stroke Diagnostics and Therapeutics Market Facts & Figures by Country (2017, 2022 & 2028) 6.1.3 U.S. 6.1.4 Canada 6.2 Asia-Pacific 6.2.1 Asia-Pacific Stroke Diagnostics and Therapeutics Market Size YoY Growth 2017-2028 6.2.2 Asia-Pacific Stroke Diagnostics and Therapeutics Market Facts & Figures by Region (2017, 2022 & 2028) 6.2.3 China 6.2.4 Japan 6.2.5 South Korea 6.2.6 India 6.2.7 Australia 6.2.8 Taiwan 6.2.9 Indonesia 6.2.10 Thailand 6.2.11 Malaysia 6.2.12 Philippines 6.3 Europe 6.3.1 Europe Stroke Diagnostics and Therapeutics Market Size YoY Growth 2017-2028 6.3.2 Europe Stroke Diagnostics and Therapeutics Market Facts & Figures by Country (2017, 2022 & 2028) 6.3.3 Germany 6.3.4 France 6.3.5 U.K. 6.3.6 Italy 6.3.7 Russia 6.4 Latin America 6.4.1 Latin America Stroke Diagnostics and Therapeutics Market Size YoY Growth 2017-2028 6.4.2 Latin America Stroke Diagnostics and Therapeutics Market Facts & Figures by Country (2017, 2022 & 2028) 6.4.3 Mexico 6.4.4 Brazil 6.4.5 Argentina 6.5 Middle East and Africa 6.5.1 Middle East and Africa Stroke Diagnostics and Therapeutics Market Size YoY Growth 2017-2028 6.5.2 Middle East and Africa Stroke Diagnostics and Therapeutics Market Facts & Figures by Country (2017, 2022 & 2028) 6.5.3 Turkey 6.5.4 Saudi Arabia 6.5.5 UAE 7 Company Profiles 7.1 Abbott Laboratories 7.1.1 Abbott Laboratories Company Details 7.1.2 Abbott Laboratories Business Overview 7.1.3 Abbott Laboratories Stroke Diagnostics and Therapeutics Introduction 7.1.4 Abbott Laboratories Revenue in Stroke Diagnostics and Therapeutics Business (2017-2022) 7.1.5 Abbott Laboratories Recent Development 7.2 Cordis 7.2.1 Cordis Company Details 7.2.2 Cordis Business Overview 7.2.3 Cordis Stroke Diagnostics and Therapeutics Introduction 7.2.4 Cordis Revenue in Stroke Diagnostics and Therapeutics Business (2017-2022) 7.2.5 Cordis Recent Development 7.3 Boston Scientific 7.3.1 Boston Scientific Company Details 7.3.2 Boston Scientific Business Overview 7.3.3 Boston Scientific Stroke Diagnostics and Therapeutics Introduction 7.3.4 Boston Scientific Revenue in Stroke Diagnostics and Therapeutics Business (2017-2022) 7.3.5 Boston Scientific Recent Development 7.4 Siemens 7.4.1 Siemens Company Details 7.4.2 Siemens Business Overview 7.4.3 Siemens Stroke Diagnostics and Therapeutics Introduction 7.4.4 Siemens Revenue in Stroke Diagnostics and Therapeutics Business (2017-2022) 7.4.5 Siemens Recent Development 7.5 Genentech 7.5.1 Genentech Company Details 7.5.2 Genentech Business Overview 7.5.3 Genentech Stroke Diagnostics and Therapeutics Introduction 7.5.4 Genentech Revenue in Stroke Diagnostics and Therapeutics Business (2017-2022) 7.5.5 Genentech Recent Development 7.6 Koninklijke Philips 7.6.1 Koninklijke Philips Company Details 7.6.2 Koninklijke Philips Business Overview 7.6.3 Koninklijke Philips Stroke Diagnostics and Therapeutics Introduction 7.6.4 Koninklijke Philips Revenue in Stroke Diagnostics and Therapeutics Business (2017-2022) 7.6.5 Koninklijke Philips Recent Development 7.7 Medtronic 7.7.1 Medtronic Company Details 7.7.2 Medtronic Business Overview 7.7.3 Medtronic Stroke Diagnostics and Therapeutics Introduction 7.7.4 Medtronic Revenue in Stroke Diagnostics and Therapeutics Business (2017-2022) 7.7.5 Medtronic Recent Development 7.8 GE Healthcare 7.8.1 GE Healthcare Company Details 7.8.2 GE Healthcare Business Overview 7.8.3 GE Healthcare Stroke Diagnostics and Therapeutics Introduction 7.8.4 GE Healthcare Revenue in Stroke Diagnostics and Therapeutics Business (2017-2022) 7.8.5 GE Healthcare Recent Development 7.9 Stryker 7.9.1 Stryker Company Details 7.9.2 Stryker Business Overview 7.9.3 Stryker Stroke Diagnostics and Therapeutics Introduction 7.9.4 Stryker Revenue in Stroke Diagnostics and Therapeutics Business (2017-2022) 7.9.5 Stryker Recent Development 7.10 Merck 7.10.1 Merck Company Details 7.10.2 Merck Business Overview 7.10.3 Merck Stroke Diagnostics and Therapeutics Introduction 7.10.4 Merck Revenue in Stroke Diagnostics and Therapeutics Business (2017-2022) 7.10.5 Merck Recent Development 8 Research Findings and Conclusion 9 Appendix 9.1 Research Methodology 9.1.1 Methodology/Research Approach 9.1.2 Data Source 9.2 Author Details 9.3 Disclaimer

List of Tables Table 1. Stroke Diagnostics and Therapeutics Market Size United States VS Global, CAGR (2017 VS 2022 VS 2028) Table 2. Stroke Diagnostics and Therapeutics Market Trends Table 3. Stroke Diagnostics and Therapeutics Market Drivers Table 4. Stroke Diagnostics and Therapeutics Market Challenges Table 5. Stroke Diagnostics and Therapeutics Market Restraints Table 6. Global Stroke Diagnostics and Therapeutics Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million) Table 7. United States Stroke Diagnostics and Therapeutics Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million) Table 8. Global Stroke Diagnostics and Therapeutics Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million) Table 9. United States Stroke Diagnostics and Therapeutics Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million) Table 10. Top Stroke Diagnostics and Therapeutics Companies in Global Market, Ranking by Revenue (2021) Table 11. Global Stroke Diagnostics and Therapeutics Revenue by Player, (US$ Million), 2017-2022 Table 12. Global Stroke Diagnostics and Therapeutics Revenue Share by Player, 2017-2022 Table 13. Global Stroke Diagnostics and Therapeutics Companies Market Concentration Ratio (CR5 and HHI) Table 14. Global Stroke Diagnostics and Therapeutics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Stroke Diagnostics and Therapeutics as of 2021) Table 15. Top Players of Stroke Diagnostics and Therapeutics in Global Market, Headquarters and Area Served Table 16. Companies Revenue in Stroke Diagnostics and Therapeutics Business (2017-2022) & (US$ Million) Type Table 17. Date of International Companies Enter into Stroke Diagnostics and Therapeutics Market Table 18. Companies Mergers & Acquisitions, Expansion Plans Table 19. Top Stroke Diagnostics and Therapeutics Players in United States Market, Ranking by Revenue (2021) Table 20. United States Stroke Diagnostics and Therapeutics Revenue by Players, (US$ Million), 2020, 2021 & 2022 Table 21. United States Stroke Diagnostics and Therapeutics Revenue Share by Players, 2020, 2021 & 2022 Table 22. Global Stroke Diagnostics and Therapeutics Market Size by Region (US$ Million): 2017 VS 2022 VS 2028 Table 23. Global Stroke Diagnostics and Therapeutics Market Size by Region (2017-2022) & (US$ Million) Table 24. Global Stroke Diagnostics and Therapeutics Market Size Forecast by Region (2023-2028) & (US$ Million) Table 25. North America Stroke Diagnostics and Therapeutics Sales in Value by Country (2017-2028) & (US$ Million) Table 26. Asia Pacific Stroke Diagnostics and Therapeutics Sales in Value by Region (2017-2028) & (US$ Million) Table 27. Europe Stroke Diagnostics and Therapeutics Sales in Value by Country (2017-2028) & (US$ Million) Table 28. Latin Americaa Stroke Diagnostics and Therapeutics Sales in Value by Country (2017-2028) & (US$ Million) Table 29. Middle East and Africa Stroke Diagnostics and Therapeutics Sales in Value by Country (2017-2028) & (US$ Million) Table 30. Abbott Laboratories Company Details Table 31. Abbott Laboratories Business Overview Table 32. Abbott Laboratories Stroke Diagnostics and Therapeutics Product Table 33. Abbott Laboratories Revenue in Stroke Diagnostics and Therapeutics Business (2017-2022) & (US$ Million) Table 34. Abbott Laboratories Recent Development Table 35. Cordis Company Details Table 36. Cordis Business Overview Table 37. Cordis Stroke Diagnostics and Therapeutics Product Table 38. Cordis Revenue in Stroke Diagnostics and Therapeutics Business (2017-2022) & (US$ Million) Table 39. Cordis Recent Development Table 40. Boston Scientific Company Details Table 41. Boston Scientific Business Overview Table 42. Boston Scientific Stroke Diagnostics and Therapeutics Product Table 43. Boston Scientific Revenue in Stroke Diagnostics and Therapeutics Business (2017-2022) & (US$ Million) Table 44. Boston Scientific Recent Development Table 45. Siemens Company Details Table 46. Siemens Business Overview Table 47. Siemens Stroke Diagnostics and Therapeutics Product Table 48. Siemens Revenue in Stroke Diagnostics and Therapeutics Business (2017-2022) & (US$ Million) Table 49. Siemens Recent Development Table 50. Genentech Company Details Table 51. Genentech Business Overview Table 52. Genentech Stroke Diagnostics and Therapeutics Product Table 53. Genentech Revenue in Stroke Diagnostics and Therapeutics Business (2017-2022) & (US$ Million) Table 54. Genentech Recent Development Table 55. Koninklijke Philips Company Details Table 56. Koninklijke Philips Business Overview Table 57. Koninklijke Philips Stroke Diagnostics and Therapeutics Product Table 58. Koninklijke Philips Revenue in Stroke Diagnostics and Therapeutics Business (2017-2022) & (US$ Million) Table 59. Koninklijke Philips Recent Development Table 60. Medtronic Company Details Table 61. Medtronic Business Overview Table 62. Medtronic Stroke Diagnostics and Therapeutics Product Table 63. Medtronic Revenue in Stroke Diagnostics and Therapeutics Business (2017-2022) & (US$ Million) Table 64. Medtronic Recent Development Table 65. GE Healthcare Company Details Table 66. GE Healthcare Business Overview Table 67. GE Healthcare Stroke Diagnostics and Therapeutics Product Table 68. GE Healthcare Revenue in Stroke Diagnostics and Therapeutics Business (2017-2022) & (US$ Million) Table 69. GE Healthcare Recent Development Table 70. Stryker Company Details Table 71. Stryker Business Overview Table 72. Stryker Stroke Diagnostics and Therapeutics Product Table 73. Stryker Revenue in Stroke Diagnostics and Therapeutics Business (2017-2022) & (US$ Million) Table 74. Stryker Recent Development Table 75. Merck Company Details Table 76. Merck Business Overview Table 77. Merck Stroke Diagnostics and Therapeutics Product Table 78. Merck Revenue in Stroke Diagnostics and Therapeutics Business (2017-2022) & (US$ Million) Table 79. Merck Recent Development Table 80. Research Programs/Design for This Report Table 81. Key Data Information from Secondary Sources Table 82. Key Data Information from Primary Sources List of Figures Figure 1. Stroke Diagnostics and Therapeutics Product Picture Figure 2. Global Stroke Diagnostics and Therapeutics Market Size, (US$ Million), 2017 VS 2022 VS 2028 Figure 3. Global Stroke Diagnostics and Therapeutics Market Size 2017-2028 (US$ Million) Figure 4. United States Stroke Diagnostics and Therapeutics Market Size, (US$ Million), 2017 VS 2022 VS 2028 Figure 5. United States Stroke Diagnostics and Therapeutics Market Size 2017-2028 (US$ Million) Figure 6. United States Stroke Diagnostics and Therapeutics Market Share in Global 2017-2028 Figure 7. Stroke Diagnostics and Therapeutics Report Years Considered Figure 8. Product Picture of Diagnostics Figure 9. Product Picture of Therapeutics Figure 10. Global Stroke Diagnostics and Therapeutics Market Share by Type in 2022 & 2028 Figure 11. Global Stroke Diagnostics and Therapeutics Market Size by Type (2017-2028) & (US$ Million) Figure 12. Global Stroke Diagnostics and Therapeutics Market Share by Type (2017-2028) Figure 13. United States Stroke Diagnostics and Therapeutics Market Share by Type in 2022 & 2028 Figure 14. United States Stroke Diagnostics and Therapeutics Market Size by Type (2017-2028) & (US$ Million) Figure 15. United States Stroke Diagnostics and Therapeutics Market Share by Type (2017-2028) Figure 16. Product Picture of Ischemic Stroke Figure 17. Product Picture of Haemorrhagic Stroke Figure 18. Global Stroke Diagnostics and Therapeutics Market Share by Application in 2022 & 2028 Figure 19. Global Stroke Diagnostics and Therapeutics Market Size by Application (2017-2028) & (US$ Million) Figure 20. Global Stroke Diagnostics and Therapeutics Market Share by Application (2017-2028) Figure 21. United States Stroke Diagnostics and Therapeutics Market Share by Application in 2022 & 2028 Figure 22. United States Stroke Diagnostics and Therapeutics Market Size by Application (2017-2028) & (US$ Million) Figure 23. United States Stroke Diagnostics and Therapeutics Market Share by Application (2017-2028) Figure 24. North America Stroke Diagnostics and Therapeutics Market Size Growth Rate 2017-2028 (US$ Million) Figure 25. U.S. Stroke Diagnostics and Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million) Figure 26. Canada Stroke Diagnostics and Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million) Figure 27. Europe Stroke Diagnostics and Therapeutics Market Size Growth Rate 2017-2028 (US$ Million) Figure 28. Germany Stroke Diagnostics and Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million) Figure 29. France Stroke Diagnostics and Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million) Figure 30. U.K. Stroke Diagnostics and Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million) Figure 31. Italy Stroke Diagnostics and Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million) Figure 32. Russia Stroke Diagnostics and Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million) Figure 33. Asia-Pacific Stroke Diagnostics and Therapeutics Market Size Growth Rate 2017-2028 (US$ Million) Figure 34. China Stroke Diagnostics and Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million) Figure 35. Japan Stroke Diagnostics and Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million) Figure 36. South Korea Stroke Diagnostics and Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million) Figure 37. India Stroke Diagnostics and Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million) Figure 38. Australia Stroke Diagnostics and Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million) Figure 39. Taiwan Stroke Diagnostics and Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million) Figure 40. Indonesia Stroke Diagnostics and Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million) Figure 41. Thailand Stroke Diagnostics and Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million) Figure 42. Malaysia Stroke Diagnostics and Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million) Figure 43. Philippines Stroke Diagnostics and Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million) Figure 44. Latin America Stroke Diagnostics and Therapeutics Market Size Growth Rate 2017-2028 (US$ Million) Figure 45. Mexico Stroke Diagnostics and Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million) Figure 46. Brazil Stroke Diagnostics and Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million) Figure 47. Argentina Stroke Diagnostics and Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million) Figure 48. Middle East & Africa Stroke Diagnostics and Therapeutics Market Size Growth Rate 2017-2028 (US$ Million) Figure 49. Turkey Stroke Diagnostics and Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million) Figure 50. Saudi Arabia Stroke Diagnostics and Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million) Figure 51. UAE Stroke Diagnostics and Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million) Figure 52. Abbott Laboratories Revenue Growth Rate in Stroke Diagnostics and Therapeutics Business (2017-2022) Figure 53. Cordis Revenue Growth Rate in Stroke Diagnostics and Therapeutics Business (2017-2022) Figure 54. Boston Scientific Revenue Growth Rate in Stroke Diagnostics and Therapeutics Business (2017-2022) Figure 55. Siemens Revenue Growth Rate in Stroke Diagnostics and Therapeutics Business (2017-2022) Figure 56. Genentech Revenue Growth Rate in Stroke Diagnostics and Therapeutics Business (2017-2022) Figure 57. Koninklijke Philips Revenue Growth Rate in Stroke Diagnostics and Therapeutics Business (2017-2022) Figure 58. Medtronic Revenue Growth Rate in Stroke Diagnostics and Therapeutics Business (2017-2022) Figure 59. GE Healthcare Revenue Growth Rate in Stroke Diagnostics and Therapeutics Business (2017-2022) Figure 60. Stryker Revenue Growth Rate in Stroke Diagnostics and Therapeutics Business (2017-2022) Figure 61. Merck Revenue Growth Rate in Stroke Diagnostics and Therapeutics Business (2017-2022) Figure 62. Bottom-up and Top-down Approaches for This Report Figure 63. Data Triangulation Figure 64. Key Executives Interviewed

Abbott Laboratories Cordis Boston Scientific Siemens Genentech Koninklijke Philips Medtronic GE Healthcare Stryker Merck